Download PDF

Other users also viewed these articles

Determinants and impact of alexithymia on quality of life in Parkinson's disease A. Alvarado-Bolaños; A. Cervantes-Arriaga; L. Zuazua-Vidal; Ó. Esquivel-Zapata; Á. Alcocer-Salas; M. Rodríguez-Violante;
Neurologia. 2023;38:334-41
Continuous intestinal infusion of levodopa¿carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community D. Santos-García; M.J. Catalán; V. Puente; F. Valldeoriola; I. Regidor; P. Mir; J. Matías-Arbelo; J.C. Parra; F. Grandas;
Neurologia. 2021;36:101-11
Beta-caryophyllene inhibits the permeability of the blood¿brain barrier in MPTP-induced parkinsonism A.R. Ramos-Molina; A.R. Tejeda-Martínez; J.M. Viveros-Paredes; V. Chaparro-Huerta; M.F. Urmeneta-Ortíz; L.J. Ramírez-Jirano; M.E. Flores-Soto;
Neurologia. 2025;40:191-203